Session: Coinfections with HIV, HBV, and HCV in Arrestees: Results from a Three-Jail Study
5097.0: Wednesday, November 19, 2003: 12:30 PM-2:00 PM
Coinfections with HIV, HBV, and HCV in Arrestees: Results from a Three-Jail Study
Purpose: This session will explore the interface of the criminal justice and public health domains through presentation of site-specific and summary results of a serologic study of HIV and viral hepatitis infections among arrestees in three major U.S. jails. Relevance: Given this Annual Meeting’s theme of “Behavior, Lifestyle, and Social Determinants of Health,” an examination of the infectious disease burden of populations interfacing with the criminal justice system can provide insight to a growing, underserved population, in particular illicit drug users. Approximately 80% of all persons who inject drugs will be arrested during their injecting careers. Approximately 82% of jail inmates in 1996 reported having used drugs, and 64% reported regular drug use. In the last 10 years, drug offenses accounted for 20% of the increase in State prison inmates and 58% of the increase in Federal prison sentences. Therefore, jails are an important venue for reaching persons whose behavior and lifestyle put them at risk for infectious diseases of public health significance. Importance: Many individuals booked into jails are at increased risk for infectious diseases, including HIV and hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Because few studies have looked at prevalence of HIV/HBV/HCV coinfections in jail populations, we examined seromarkers for HIV, HBV and HCV in geographically diverse jail populations. The presentations will present data demonstrating 2-3% seroprevalence of HIV infection, and high rates of HBV and HCV coinfection: anti-HBc 40%-43%, HBsAg 5%-9%, and anti-HCV 32%-41%.
Learning Objectives: At the end of this session, participants will be able to: 1. Give an overview of jail population characteristics putting arrested individuals at risk for infectious diseases 2. Describe the epidemiology of HIV, hepatitis B and hepatitis C coinfection in three large urban jails 3. Identify opportunities for prevalence studies, and for bloodborne disease prevention in other local jail settings
See individual abstracts for presenting author's disclosure statement and author's information.
Organizer(s):Cindy Weinbaum, MD, MPH
Presider(s):Cindy Weinbaum, MD, MPH
12:30 PMIntroductory Remarks
12:35 PMSeroprevalence of HIV, HBV, and HCV co-infection among persons entering a county jail, Detroit, MI
Vivian Griffin, BS, Garald Goza, MS, Anna Satcher, MPH
12:55 PMHIV and viral hepatitis coinfections among persons entering a Chicago, IL correctional facility
Huma M. Soofi, MPH, Nicoline Tablan, MPH, Fikirte Wagaw, MPH, Nanette Benbow, MAS
1:15 PMHIV, HBV, HCV, and co-infection among persons arrested in San Francisco, 1999 – 2000
Andrea A Kim, MPH, Willi McFarland, MD, PhD, Charlotte K Kent, MPH, Robert Kohn, MPH, Ameera Snell, Brian Louie, Joe Goldenson, MD, Jeffrey D Klausner, MD, MPH, Keith A. Bordelon, MSPH, Keith M. Sabin, PhD, MPH
1:35 PMDiscussion
1:50 PMConcluding Remarks
Organized by:Epidemiology
Endorsed by:Community Health Planning and Policy Development; HIV/AIDS; Socialist Caucus
CE Credits:CME, Health Education (CHES), Nursing, Pharmacy

The 131st Annual Meeting (November 15-19, 2003) of APHA